Announcements Trials
Browse Landscape

Phase

Phase NA 52Phase 2 10Phase 1 5Phase 4 4Phase EARLY_PHASE1 3Phase 3 3Phase 2/3 3Phase 1/2 1

Status

Completed 33Terminated 13Unknown 10Recruiting 3Withdrawn 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 261Breast 185Thoracic 169Genitourinary 132Head & Neck 98Lymphoid 90Gynecologic 78Other hematologic neoplasm 72CNS 48Plasma cell 45Dermatologic 28Sarcoma 21Tumor-Agnostic 16Other solid neoplasm 14Endocrine 14Myeloid 13NET 12Classical hematology 10Other neoplasm 3Other 3

Conditions

Polycystic Ovary Syndrome 1Obesity 1Chemotherapy-induced Peripheral Neuropathy (CIPN) 1Acute Graft Versus Host Disease 1

Interventions

semaglutide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Other × Clear all
NCT07047456 2025-12-23

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT

Anhui Provincial Hospital

Phase 3 Recruiting
134 enrolled
Other

Acute Graft Versus Host Disease

NCT05819853 2025-08-28

RESTORE

University of Colorado, Denver

Phase 3 Recruiting
80 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT06994507 2025-08-06

GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer

Qilu Pharmaceutical Co., Ltd.

Phase 3 Recruiting
352 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡